Tenaya Therapeutics Inc
XNAS:TNYA 4:00:00 PM EDT
| Market Cap (Intraday) | 157.37M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.70 |
| 50-Day MA | $0.73 |
| 200-Day MA | $1.02 |
Tenaya Therapeutics Inc Stock, XNAS:TNYA
171 Oyster Point Boulevard, 5th floor, Suite 500, South San Francisco, California 94080
United States of America
Phone: +1.650.825.6900
Number of Employees: 97
Description
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.